Discussion

Pediatric Infectious Disease Journal

Volumn 24, Issue 11 SUPPL., 2005, Pages

  Friedlander, Samuel L ^a,e   Jackson, Daniel J ^a   Gangnon, Ronald E ^a,b   Evans, Michael D ^a   Li, Zhanhai ^a   Roberg, Kathy A ^a   Anderson, Elizabeth L ^a   Carlson Dakes, Kirstin T ^a   Adler, Kiva J ^a   Gilbertson White, Stephanie ^a   Pappas, Tressa E ^a   DaSilva, Douglas F ^a   Tisler, Christopher J ^a   Pleiss, Lisa E ^a   Mikus, Lance D ^a   Rosenthal, Louis A ^a   Shult, Peter A ^a   Kirk, Carol J ^c   Reisdorf, Erik ^c   Hoffjan, Sabine ^d   Gern, James E ^a   Lemanske Jr , Robert F ^a   more..

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5; CYTOKINE;

ALLERGY; ASTHMA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC ASSOCIATION; HEREDITY; HUMAN; NOTE; PRIORITY JOURNAL; SENSITIZATION; ARTICLE; CHILDHOOD DISEASE; CYTOKINE RELEASE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HELPER CELL; HIGH RISK POPULATION; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; PATHOGENESIS; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; WHEEZING; ABNORMAL RESPIRATORY SOUND; ANIMAL; CHILD; GENETICS; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; INFANT; METABOLISM; MOUSE; NEWBORN; PRESCHOOL CHILD; REVIEW; VIROLOGY;

ANIMALS; ASTHMA; CHILD; CHILD, PRESCHOOL; CYTOKINES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFANT; INFANT, NEWBORN; MICE; RESPIRATORY SOUNDS; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 33644817193     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000187273.47390.01     Document Type: Article

References (70)

1. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med. 1981;305:841-846.
2. Welliver RC, Sun M, Rinaldo D, Ogra PL. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing after bronchiolitis. J Pediatr. 1986;109:776-780.
3. Welliver RC, Wong DT, Sun M, McCarthy N. Parainfluenza virus bronchiolitis: epidemiology and pathogenesis. Am J Dis Child. 1986;140:34-40.
4. Alwan WH, Kozlowska WJ, Openshaw PJ. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med. 1994;179:81-89.
5. Einarsson O, Geba GP, Panuska JR, Zhu Z, Landry M, Elias JA. Asthma-associated viruses specifically induce lung stromal cells to produce interleukin-11, a mediator of airways hyperreactivity. Chest. 1995;107:132S-133S.
6. Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988;319:1112-1117.
7. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life: The Group Health Medical Associates. N Engl J Med. 1995;332:133-138.
8. Morgan WJ, Martinez FD. Risk factors for developing wheezing and asthma in childhood. Pediatr Clin N Am. 1992;39:1185-1203.
9. Nakao F, Ihara K, Kusuhara K, et al. Association of IFN-γ and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J Allergy Clin Immunol. 2001;107(3 pt 1):499-504.
10. Hoffjan S, Nicolae D, Ostrovnaya I, et al. Gene-environment interaction effects on the development of immune responses in the 1st year of life. Am J Hum Genet. 2005;76:696-704.
11. Haitchi HM, Powell RM, Shaw TJ, et al. ADAM33 expression in asthmatic airways and human embryonic lungs. Am J Respir Crit Care Med. 2005;171:958-965.
12. Bardin PG, Fraenkel DJ, Sanderson G, et al. Amplified rhinovirus colds in atopic subjects. Clin Exp Allergy. 1994;24:457-464.
13. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171:137-141.
14. Frick OL, German DF, Mills J. Development of allergy in children, I: association with virus infections. J Allergy Clin Immunol. 1979;63:228-241.
15. Frick OL. Effect of respiratory and other virus infections on IgE immunoregulation. J Allergy Clin Immunol. 1986;78(5 pt 2):1013-1018.
16. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest. 1994;94:2200-2208.
17. Lemanske RF Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest. 1989;83:1-10.
18. Schwarze J, Johnston SL. Unravelling synergistic immune interactions between respiratory virus infections and allergic airway inflammation. Clin Exp Allergy. 2004;34:1153-1155.
19. Friedlander S, Busse W. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol. 2005;116:267-273.
20. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis. 1976;113:131-139.
21. Grünberg K, Timmers MC, de Klerk EPA, Dick EC, Sterk PJ. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med. 1999;160:1375-1380.
22. Stokes GM, Milner AD, Hodges IGC, Groggins RC. Lung function abnormalities after acute bronchiolitis. J Pediatr. 1981;98:871-874.
23. Wohl MEB, Stigol L, Mead J. Resistance of the total respiratory system in healthy infants and infants with bronchiolitis. Pediatrics. 1969;43:495-509.
24. Hall CB, Hall WJ, Gala CL, MaGill FB, Leddy JP. Long-term prospective study of children after respiratory syncytial virus infection. J Pediatr. 1984;105:358-364.
25. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541-545.
26. Openshaw PJM. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin Immunopathol. 1995;17:187-201.
27. Gern JE, Lemanske RF Jr, Busse WW. Early life origins of asthma. J Clin Invest. 1999;104:837-843.
28. Prescott SL, Macaubas C, Holt BJ, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol. 1998;160:4730-4737.
29. Halonen M, Martinez FD. A deficient capacity to produce interferon-γ: is it a risk for asthma and allergies? Clin Exp Allergy. 1997;27:1234-1236.
30. Prescott SL, Holt PG. Abnormalities in cord blood mononuclear cytokine production as a predictor of later atopic disease in childhood. Clin Exp Allergy. 1998;28:1313-1316.
31. Tang MLK, Kemp AS, Thorburn J, Hill DJ. Reduced interferon-γ secretion in neonates and subsequent atopy. Lancet. 1994;344:983-985.
32. Matsui E, Kaneko H, Teramoto T, et al. Reduced IFNγ production in response to IL-12 stimulation and/or reduced IL-12 production in atopic patients. Clin Exp Allergy. 2000;30:1250-1256.
33. Williams TJ, Jones CA, Miles EA, Warner JO, Warner JA. Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms. J Allergy Clin Immunol. 2000;105:951-959.
34. Hoekstra MO, Hoekstra Y, De Reus D, Rutgers B, Gerritsen J, Kauffman HF. Interleukin-4, interferon-γ and interleukin-5 in peripheral blood of children with moderate atopic asthma. Clin Exp Allergy. 1997;27:1254-1260.
35. Martinez FD, Stern DA, Wright AL, Holberg CJ, Taussig LM, Halonen M. Association of interleukin-2 and interferon-γ production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J Allergy Clin Immunol. 1995;96(5 pt 1):652-660.
36. Chou CC, Huang MS, Hsieh KH, Chiang BL. Reduced IL-12 level correlates with decreased IFN-γ secreting T cells but not natural killer cell activity in asthmatic children. Ann Allergy Asthma Immunol. 1999;82:479-484.
37. van der Pouw Kraan TCTM, Boeije LCM, de Groot ER et al. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma. J Immunol. 1997;158:5560-5565.
38. Koning H, Neijens HJ, Baert MR, Oranje AP, Savelkoul HF. T cells subsets and cytokines in allergic and non-allergic children, II: analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine. 1997;9:427-436.
39. Mamane Y, Heylbroeck C, Genin P, et al. Interferon regulatory factors: the next generation. Gene. 1999;237:1-14.
40. + T cells and early sensitization among infants at high risk of atopy. J Allergy Clin Immunol. 2004;113:710-716.
41. Bufford JD, Gern JE. The hygiene hypothesis revisited. Immunol Allergy Clin North Am. 2005;25:247-262.
42. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299:1259-1260.
43. Mattes J, Karmaus W. The use of antibiotics in the first year of life and development of asthma: which comes first? Clin Exp Allergy. 1999;29:729-732.
44. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science. 1997;275:77-79.
45. Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet. 1996;347:1792-1796.
46. Matricardi PM, Rosmini F, Ferrigno L, et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ. 1997;314:999-1003.
47. McIntire JJ, Umetsu SE, Macaubas C, et al. Immunology: hepatitis A virus link to atopic disease. Nature. 2003;425:576.
48. Ball TM, Castro-Rodríguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med. 2000;343:538-543.
49. Martinez FD. Maturation of immune responses at the beginning of asthma. J Allergy Clin Immunol. 1999;103(3 pt 1):355-361.
50. Warner JA, Jones CA, Williams TJ, Warner JO. Maternal programming in asthma and allergy. Clin Exp Allergy. 1998;28(suppl 5):35-38.
51. Bodner CH, Ross S, Little J, et al. Risk factors for adult onset wheeze: a case control study. Am J Respir Crit Care Med. 1998;157:35-42.
52. Kraft M, Lewis C, Pham D, Chu HW. IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J Allergy Clin Immunol. 2001;107:602-606.
53. Laporte JC, Moore PE, Baraldo S, et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med. 2001;164:141-148.
54. Grunig G, Warnock M, Wakil AE, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998;282:2261-2263.
55. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282:2258-2261.
56. Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999;103:779-788.
57. Kampf C, Relova AJ, Sandler S, Roomans GM. Effects of TNF-α, IFN-γ and IL-beta on normal human bronchial epithelial cells. Eur Respir J. 1999;14:84-91.
58. Cohn L, Herrick C, Niu N, Homer R, Bottomly K. IL-4 promotes airway eosinophilia by suppressing IFN-γ production: defining a role for IFN-γ in the regulation of allergic airway inflammation. J Immunol. 2001;166:2760-2767.
59. Ford JG, Rennick D, Donaldson DD, et al. IL-13 and IFN-γ: interactions in lung inflammation. J Immunol. 2001;167:1769-1777.
60. Sorkness RL, Castleman WL, Kumar A, Kaplan MR, Lemanske RF Jr. Prevention of chronic postbronchiolitis airway sequelae with IFN-γ treatment in rats. Am J Respir Crit Care Med. 1999;160:705-710.
61. Lemanske RF Jr. The childhood origins of asthma (COAST) study. Pediatr Allergy Immunol. 2002;13(suppl 15):38-43.
62. Gern JE, Martin MS, Anklam KA, et al. Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol. 2002;13:386-393.
63. Neaville WA, Tisler C, Bhattacharya A, et al. Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life. J Allergy Clin Immunol. 2003;11:740-746.
64. Hoffjan S, Ostrovnaja I, Nicolae D, et al. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J Allergy Clin Immunol. 2004;113:511-518.
65. Copenhaver CC, Gern JE, Li Z, et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med. 2004;170:175-180.
66. Lemanske R, Jackson D, Gangnon R, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116:571-577.
67. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy: the first sign of childhood asthma? J Allergy Clin Immunol. 2003;111:66-71.
68. Mandhane PJ, Greene JM, Cowan JO, Taylor DR, Sears MR. Sex differences in factors associated with childhood- and adolescent-onset wheeze. Am J Respir Crit Care Med. 2005;172:45-54.
69. Haby MM, Marks GB, Peat JK, Leeder SR. Daycare attendance before the age of two protects against atopy in preschool age children. Pediatr Pulmonol. 2000;30:377-384.
70. Bourgain C, Hoffjan S, Nicolae R, et al. Novel case-control test in a founder population identifies P-selectin as an atopy-susceptibility locus. Am J Hum Genet. 2003;73:612-626.